nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—DHFR—Methotrexate—systemic scleroderma	0.214	0.29	CbGbCtD
Trimethoprim—TYMS—Methotrexate—systemic scleroderma	0.149	0.202	CbGbCtD
Trimethoprim—CYP2C8—Mometasone—systemic scleroderma	0.106	0.144	CbGbCtD
Trimethoprim—ABCB1—Lisinopril—systemic scleroderma	0.0485	0.0657	CbGbCtD
Trimethoprim—CYP2C9—Leflunomide—systemic scleroderma	0.0477	0.0646	CbGbCtD
Trimethoprim—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0422	0.0572	CbGbCtD
Trimethoprim—ABCB1—Captopril—systemic scleroderma	0.0363	0.0492	CbGbCtD
Trimethoprim—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0286	0.0387	CbGbCtD
Trimethoprim—ABCB1—Prednisone—systemic scleroderma	0.0229	0.031	CbGbCtD
Trimethoprim—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0171	0.0232	CbGbCtD
Trimethoprim—CYP2C9—cardial valve—systemic scleroderma	0.014	0.444	CbGeAlD
Trimethoprim—CYP3A4—Prednisone—systemic scleroderma	0.0137	0.0186	CbGbCtD
Trimethoprim—ABCB1—Methotrexate—systemic scleroderma	0.0115	0.0155	CbGbCtD
Trimethoprim—TYMS—connective tissue—systemic scleroderma	0.00192	0.0609	CbGeAlD
Trimethoprim—DHFR—connective tissue—systemic scleroderma	0.0019	0.0603	CbGeAlD
Trimethoprim—TYMS—smooth muscle tissue—systemic scleroderma	0.00175	0.0557	CbGeAlD
Trimethoprim—TYMS—skin of body—systemic scleroderma	0.00173	0.055	CbGeAlD
Trimethoprim—TYMS—digestive system—systemic scleroderma	0.00138	0.044	CbGeAlD
Trimethoprim—DHFR—digestive system—systemic scleroderma	0.00137	0.0435	CbGeAlD
Trimethoprim—TYMS—tendon—systemic scleroderma	0.00132	0.0418	CbGeAlD
Trimethoprim—DHFR—tendon—systemic scleroderma	0.0013	0.0414	CbGeAlD
Trimethoprim—TYMS—lung—systemic scleroderma	0.00116	0.0367	CbGeAlD
Trimethoprim—DHFR—lung—systemic scleroderma	0.00114	0.0364	CbGeAlD
Trimethoprim—ABCB1—blood vessel—systemic scleroderma	0.00088	0.028	CbGeAlD
Trimethoprim—CYP2C9—digestive system—systemic scleroderma	0.000604	0.0192	CbGeAlD
Trimethoprim—TYMS—Clobetasol propionate—Mometasone—systemic scleroderma	0.000534	0.117	CbGdCrCtD
Trimethoprim—TYMS—Flunisolide—Mometasone—systemic scleroderma	0.000527	0.115	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Mometasone—systemic scleroderma	0.000522	0.114	CbGdCrCtD
Trimethoprim—TYMS—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000509	0.111	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Mometasone—systemic scleroderma	0.000481	0.105	CbGdCrCtD
Trimethoprim—CYP3A4—digestive system—systemic scleroderma	0.000461	0.0146	CbGeAlD
Trimethoprim—TYMS—Budesonide—Mometasone—systemic scleroderma	0.000422	0.0923	CbGdCrCtD
Trimethoprim—ABCB1—digestive system—systemic scleroderma	0.000326	0.0104	CbGeAlD
Trimethoprim—TYMS—Clobetasol propionate—Prednisone—systemic scleroderma	0.000291	0.0637	CbGdCrCtD
Trimethoprim—Loss of consciousness—Lisinopril—systemic scleroderma	0.000291	0.00129	CcSEcCtD
Trimethoprim—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00029	0.00128	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000289	0.00128	CcSEcCtD
Trimethoprim—Cough—Lisinopril—systemic scleroderma	0.000289	0.00128	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000287	0.00127	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Prednisone—systemic scleroderma	0.000287	0.0629	CbGdCrCtD
Trimethoprim—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000286	0.00127	CcSEcCtD
Trimethoprim—Anorexia—Mycophenolic acid—systemic scleroderma	0.000286	0.00127	CcSEcCtD
Trimethoprim—TYMS—Triamcinolone—Prednisone—systemic scleroderma	0.000284	0.0623	CbGdCrCtD
Trimethoprim—Insomnia—Leflunomide—systemic scleroderma	0.000284	0.00126	CcSEcCtD
Trimethoprim—Arthralgia—Lisinopril—systemic scleroderma	0.000282	0.00125	CcSEcCtD
Trimethoprim—Myalgia—Lisinopril—systemic scleroderma	0.000282	0.00125	CcSEcCtD
Trimethoprim—Anxiety—Lisinopril—systemic scleroderma	0.000281	0.00124	CcSEcCtD
Trimethoprim—Dyspnoea—Leflunomide—systemic scleroderma	0.00028	0.00124	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00028	0.00124	CcSEcCtD
Trimethoprim—Lethargy—Methotrexate—systemic scleroderma	0.000278	0.00123	CcSEcCtD
Trimethoprim—Dyspepsia—Leflunomide—systemic scleroderma	0.000277	0.00122	CcSEcCtD
Trimethoprim—Pancreatitis—Prednisone—systemic scleroderma	0.000277	0.00122	CcSEcCtD
Trimethoprim—Vomiting—Mometasone—systemic scleroderma	0.000276	0.00122	CcSEcCtD
Trimethoprim—Feeling abnormal—Azathioprine—systemic scleroderma	0.000274	0.00121	CcSEcCtD
Trimethoprim—Rash—Mometasone—systemic scleroderma	0.000274	0.00121	CcSEcCtD
Trimethoprim—Dermatitis—Mometasone—systemic scleroderma	0.000274	0.00121	CcSEcCtD
Trimethoprim—Decreased appetite—Leflunomide—systemic scleroderma	0.000273	0.00121	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000273	0.00121	CcSEcCtD
Trimethoprim—ABCB1—lung—systemic scleroderma	0.000272	0.00865	CbGeAlD
Trimethoprim—Confusional state—Lisinopril—systemic scleroderma	0.000272	0.00121	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000272	0.0012	CcSEcCtD
Trimethoprim—Headache—Mometasone—systemic scleroderma	0.000272	0.0012	CcSEcCtD
Trimethoprim—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000272	0.0012	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000271	0.0012	CcSEcCtD
Trimethoprim—Insomnia—Mycophenolic acid—systemic scleroderma	0.000271	0.0012	CcSEcCtD
Trimethoprim—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00027	0.0012	CcSEcCtD
Trimethoprim—Pruritus—Captopril—systemic scleroderma	0.00027	0.00119	CcSEcCtD
Trimethoprim—Constipation—Leflunomide—systemic scleroderma	0.000269	0.00119	CcSEcCtD
Trimethoprim—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000267	0.00118	CcSEcCtD
Trimethoprim—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000266	0.00118	CcSEcCtD
Trimethoprim—Shock—Lisinopril—systemic scleroderma	0.000266	0.00118	CcSEcCtD
Trimethoprim—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00117	CcSEcCtD
Trimethoprim—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000264	0.00117	CcSEcCtD
Trimethoprim—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000264	0.00117	CcSEcCtD
Trimethoprim—Neutropenia—Prednisone—systemic scleroderma	0.000264	0.00117	CcSEcCtD
Trimethoprim—Abdominal pain—Azathioprine—systemic scleroderma	0.000263	0.00116	CcSEcCtD
Trimethoprim—Body temperature increased—Azathioprine—systemic scleroderma	0.000263	0.00116	CcSEcCtD
Trimethoprim—Skin disorder—Lisinopril—systemic scleroderma	0.000262	0.00116	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Prednisone—systemic scleroderma	0.000262	0.0574	CbGdCrCtD
Trimethoprim—Diarrhoea—Captopril—systemic scleroderma	0.000261	0.00116	CcSEcCtD
Trimethoprim—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000261	0.00115	CcSEcCtD
Trimethoprim—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00115	CcSEcCtD
Trimethoprim—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00115	CcSEcCtD
Trimethoprim—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00115	CcSEcCtD
Trimethoprim—Feeling abnormal—Leflunomide—systemic scleroderma	0.000259	0.00115	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000259	0.00115	CcSEcCtD
Trimethoprim—Nausea—Mometasone—systemic scleroderma	0.000258	0.00114	CcSEcCtD
Trimethoprim—Anorexia—Lisinopril—systemic scleroderma	0.000257	0.00114	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000257	0.00114	CcSEcCtD
Trimethoprim—Ataxia—Methotrexate—systemic scleroderma	0.000256	0.00114	CcSEcCtD
Trimethoprim—Constipation—Mycophenolic acid—systemic scleroderma	0.000256	0.00114	CcSEcCtD
Trimethoprim—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00113	CcSEcCtD
Trimethoprim—Cough—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00112	CcSEcCtD
Trimethoprim—Dizziness—Captopril—systemic scleroderma	0.000252	0.00112	CcSEcCtD
Trimethoprim—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000251	0.00111	CcSEcCtD
Trimethoprim—Depression—Prednisone—systemic scleroderma	0.000251	0.00111	CcSEcCtD
Trimethoprim—Urticaria—Leflunomide—systemic scleroderma	0.00025	0.00111	CcSEcCtD
Trimethoprim—Abdominal pain—Leflunomide—systemic scleroderma	0.000248	0.0011	CcSEcCtD
Trimethoprim—Body temperature increased—Leflunomide—systemic scleroderma	0.000248	0.0011	CcSEcCtD
Trimethoprim—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000247	0.00109	CcSEcCtD
Trimethoprim—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00109	CcSEcCtD
Trimethoprim—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00109	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000247	0.00109	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000246	0.00109	CcSEcCtD
Trimethoprim—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00109	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000246	0.00109	CcSEcCtD
Trimethoprim—Hypersensitivity—Azathioprine—systemic scleroderma	0.000245	0.00109	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000245	0.00109	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00109	CcSEcCtD
Trimethoprim—Insomnia—Lisinopril—systemic scleroderma	0.000244	0.00108	CcSEcCtD
Trimethoprim—Vomiting—Captopril—systemic scleroderma	0.000242	0.00107	CcSEcCtD
Trimethoprim—Dyspnoea—Lisinopril—systemic scleroderma	0.000241	0.00107	CcSEcCtD
Trimethoprim—Rash—Captopril—systemic scleroderma	0.00024	0.00106	CcSEcCtD
Trimethoprim—Dermatitis—Captopril—systemic scleroderma	0.00024	0.00106	CcSEcCtD
Trimethoprim—Headache—Captopril—systemic scleroderma	0.000239	0.00106	CcSEcCtD
Trimethoprim—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00106	CcSEcCtD
Trimethoprim—Dyspepsia—Lisinopril—systemic scleroderma	0.000238	0.00105	CcSEcCtD
Trimethoprim—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000237	0.00105	CcSEcCtD
Trimethoprim—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000237	0.00105	CcSEcCtD
Trimethoprim—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000237	0.00105	CcSEcCtD
Trimethoprim—Decreased appetite—Lisinopril—systemic scleroderma	0.000235	0.00104	CcSEcCtD
Trimethoprim—Eosinophilia—Methotrexate—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Trimethoprim—Shock—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Trimethoprim—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000232	0.00103	CcSEcCtD
Trimethoprim—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000232	0.00103	CcSEcCtD
Trimethoprim—Hypersensitivity—Leflunomide—systemic scleroderma	0.000232	0.00103	CcSEcCtD
Trimethoprim—Pancreatitis—Methotrexate—systemic scleroderma	0.000231	0.00102	CcSEcCtD
Trimethoprim—Constipation—Lisinopril—systemic scleroderma	0.000231	0.00102	CcSEcCtD
Trimethoprim—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00023	0.00102	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Prednisone—systemic scleroderma	0.00023	0.0503	CbGdCrCtD
Trimethoprim—Diarrhoea—Azathioprine—systemic scleroderma	0.000228	0.00101	CcSEcCtD
Trimethoprim—Nausea—Captopril—systemic scleroderma	0.000227	0.001	CcSEcCtD
Trimethoprim—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000999	CcSEcCtD
Trimethoprim—Hallucination—Prednisone—systemic scleroderma	0.000225	0.000995	CcSEcCtD
Trimethoprim—Pancytopenia—Methotrexate—systemic scleroderma	0.000224	0.000991	CcSEcCtD
Trimethoprim—Feeling abnormal—Lisinopril—systemic scleroderma	0.000223	0.000985	CcSEcCtD
Trimethoprim—Pruritus—Leflunomide—systemic scleroderma	0.000222	0.000985	CcSEcCtD
Trimethoprim—Connective tissue disorder—Prednisone—systemic scleroderma	0.000222	0.000982	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000221	0.000978	CcSEcCtD
Trimethoprim—Neutropenia—Methotrexate—systemic scleroderma	0.00022	0.000976	CcSEcCtD
Trimethoprim—TYMS—Danazol—Prednisone—systemic scleroderma	0.00022	0.0482	CbGdCrCtD
Trimethoprim—Dizziness—Azathioprine—systemic scleroderma	0.00022	0.000974	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000955	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000215	0.000953	CcSEcCtD
Trimethoprim—Diarrhoea—Leflunomide—systemic scleroderma	0.000215	0.000952	CcSEcCtD
Trimethoprim—Urticaria—Lisinopril—systemic scleroderma	0.000215	0.00095	CcSEcCtD
Trimethoprim—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000948	CcSEcCtD
Trimethoprim—Body temperature increased—Lisinopril—systemic scleroderma	0.000213	0.000945	CcSEcCtD
Trimethoprim—Abdominal pain—Lisinopril—systemic scleroderma	0.000213	0.000945	CcSEcCtD
Trimethoprim—Pruritus—Mycophenolic acid—systemic scleroderma	0.000212	0.000939	CcSEcCtD
Trimethoprim—Vomiting—Azathioprine—systemic scleroderma	0.000212	0.000937	CcSEcCtD
Trimethoprim—Pneumonia—Methotrexate—systemic scleroderma	0.000211	0.000936	CcSEcCtD
Trimethoprim—Eye disorder—Prednisone—systemic scleroderma	0.000211	0.000934	CcSEcCtD
Trimethoprim—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000934	CcSEcCtD
Trimethoprim—Infestation NOS—Methotrexate—systemic scleroderma	0.00021	0.000931	CcSEcCtD
Trimethoprim—Infestation—Methotrexate—systemic scleroderma	0.00021	0.000931	CcSEcCtD
Trimethoprim—Rash—Azathioprine—systemic scleroderma	0.00021	0.000929	CcSEcCtD
Trimethoprim—Dermatitis—Azathioprine—systemic scleroderma	0.00021	0.000928	CcSEcCtD
Trimethoprim—Depression—Methotrexate—systemic scleroderma	0.00021	0.000928	CcSEcCtD
Trimethoprim—Headache—Azathioprine—systemic scleroderma	0.000208	0.000923	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000208	0.000923	CcSEcCtD
Trimethoprim—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000922	CcSEcCtD
Trimethoprim—Dizziness—Leflunomide—systemic scleroderma	0.000208	0.00092	CcSEcCtD
Trimethoprim—Renal failure—Methotrexate—systemic scleroderma	0.000207	0.000915	CcSEcCtD
Trimethoprim—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000911	CcSEcCtD
Trimethoprim—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000205	0.000908	CcSEcCtD
Trimethoprim—Stomatitis—Methotrexate—systemic scleroderma	0.000205	0.000907	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000905	CcSEcCtD
Trimethoprim—Immune system disorder—Prednisone—systemic scleroderma	0.000204	0.000903	CcSEcCtD
Trimethoprim—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000896	CcSEcCtD
Trimethoprim—Haematuria—Methotrexate—systemic scleroderma	0.0002	0.000887	CcSEcCtD
Trimethoprim—Vomiting—Leflunomide—systemic scleroderma	0.0002	0.000885	CcSEcCtD
Trimethoprim—Hypersensitivity—Lisinopril—systemic scleroderma	0.000199	0.000881	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000199	0.00088	CcSEcCtD
Trimethoprim—Dizziness—Mycophenolic acid—systemic scleroderma	0.000198	0.000878	CcSEcCtD
Trimethoprim—Epistaxis—Methotrexate—systemic scleroderma	0.000198	0.000878	CcSEcCtD
Trimethoprim—Rash—Leflunomide—systemic scleroderma	0.000198	0.000877	CcSEcCtD
Trimethoprim—Dermatitis—Leflunomide—systemic scleroderma	0.000198	0.000877	CcSEcCtD
Trimethoprim—Mental disorder—Prednisone—systemic scleroderma	0.000198	0.000876	CcSEcCtD
Trimethoprim—Nausea—Azathioprine—systemic scleroderma	0.000198	0.000875	CcSEcCtD
Trimethoprim—Headache—Leflunomide—systemic scleroderma	0.000197	0.000872	CcSEcCtD
Trimethoprim—Erythema—Prednisone—systemic scleroderma	0.000197	0.00087	CcSEcCtD
Trimethoprim—Malnutrition—Prednisone—systemic scleroderma	0.000197	0.00087	CcSEcCtD
Trimethoprim—Agranulocytosis—Methotrexate—systemic scleroderma	0.000196	0.000868	CcSEcCtD
Trimethoprim—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000863	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000857	CcSEcCtD
Trimethoprim—Pruritus—Lisinopril—systemic scleroderma	0.000191	0.000846	CcSEcCtD
Trimethoprim—Vomiting—Mycophenolic acid—systemic scleroderma	0.000191	0.000844	CcSEcCtD
Trimethoprim—Rash—Mycophenolic acid—systemic scleroderma	0.000189	0.000837	CcSEcCtD
Trimethoprim—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000189	0.000836	CcSEcCtD
Trimethoprim—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000832	CcSEcCtD
Trimethoprim—Headache—Mycophenolic acid—systemic scleroderma	0.000188	0.000832	CcSEcCtD
Trimethoprim—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000828	CcSEcCtD
Trimethoprim—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000828	CcSEcCtD
Trimethoprim—Nausea—Leflunomide—systemic scleroderma	0.000187	0.000827	CcSEcCtD
Trimethoprim—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000186	0.000825	CcSEcCtD
Trimethoprim—Urethral disorder—Methotrexate—systemic scleroderma	0.000185	0.000819	CcSEcCtD
Trimethoprim—Diarrhoea—Lisinopril—systemic scleroderma	0.000185	0.000818	CcSEcCtD
Trimethoprim—Agitation—Prednisone—systemic scleroderma	0.000181	0.0008	CcSEcCtD
Trimethoprim—Angioedema—Prednisone—systemic scleroderma	0.00018	0.000795	CcSEcCtD
Trimethoprim—Dizziness—Lisinopril—systemic scleroderma	0.000179	0.000791	CcSEcCtD
Trimethoprim—Erythema multiforme—Methotrexate—systemic scleroderma	0.000178	0.00079	CcSEcCtD
Trimethoprim—Nausea—Mycophenolic acid—systemic scleroderma	0.000178	0.000789	CcSEcCtD
Trimethoprim—Vertigo—Prednisone—systemic scleroderma	0.000177	0.000782	CcSEcCtD
Trimethoprim—Eye disorder—Methotrexate—systemic scleroderma	0.000176	0.000781	CcSEcCtD
Trimethoprim—Syncope—Prednisone—systemic scleroderma	0.000176	0.00078	CcSEcCtD
Trimethoprim—Tinnitus—Methotrexate—systemic scleroderma	0.000176	0.000779	CcSEcCtD
Trimethoprim—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000772	CcSEcCtD
Trimethoprim—Loss of consciousness—Prednisone—systemic scleroderma	0.000173	0.000765	CcSEcCtD
Trimethoprim—Vomiting—Lisinopril—systemic scleroderma	0.000172	0.00076	CcSEcCtD
Trimethoprim—Immune system disorder—Methotrexate—systemic scleroderma	0.00017	0.000755	CcSEcCtD
Trimethoprim—Rash—Lisinopril—systemic scleroderma	0.00017	0.000754	CcSEcCtD
Trimethoprim—Convulsion—Prednisone—systemic scleroderma	0.00017	0.000754	CcSEcCtD
Trimethoprim—Dermatitis—Lisinopril—systemic scleroderma	0.00017	0.000753	CcSEcCtD
Trimethoprim—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00017	0.000753	CcSEcCtD
Trimethoprim—Headache—Lisinopril—systemic scleroderma	0.000169	0.000749	CcSEcCtD
Trimethoprim—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000741	CcSEcCtD
Trimethoprim—Arthralgia—Prednisone—systemic scleroderma	0.000167	0.000741	CcSEcCtD
Trimethoprim—Myalgia—Prednisone—systemic scleroderma	0.000167	0.000741	CcSEcCtD
Trimethoprim—Anxiety—Prednisone—systemic scleroderma	0.000167	0.000738	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000166	0.000736	CcSEcCtD
Trimethoprim—Mental disorder—Methotrexate—systemic scleroderma	0.000165	0.000732	CcSEcCtD
Trimethoprim—Erythema—Methotrexate—systemic scleroderma	0.000164	0.000727	CcSEcCtD
Trimethoprim—Malnutrition—Methotrexate—systemic scleroderma	0.000164	0.000727	CcSEcCtD
Trimethoprim—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000717	CcSEcCtD
Trimethoprim—Nausea—Lisinopril—systemic scleroderma	0.00016	0.00071	CcSEcCtD
Trimethoprim—Anaphylactic shock—Prednisone—systemic scleroderma	0.00016	0.00071	CcSEcCtD
Trimethoprim—Shock—Prednisone—systemic scleroderma	0.000158	0.000699	CcSEcCtD
Trimethoprim—Nervous system disorder—Prednisone—systemic scleroderma	0.000157	0.000696	CcSEcCtD
Trimethoprim—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000693	CcSEcCtD
Trimethoprim—Skin disorder—Prednisone—systemic scleroderma	0.000156	0.00069	CcSEcCtD
Trimethoprim—Anorexia—Prednisone—systemic scleroderma	0.000153	0.000677	CcSEcCtD
Trimethoprim—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000666	CcSEcCtD
Trimethoprim—Rash—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000661	CcSEcCtD
Trimethoprim—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000149	0.00066	CcSEcCtD
Trimethoprim—Headache—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000656	CcSEcCtD
Trimethoprim—Vertigo—Methotrexate—systemic scleroderma	0.000148	0.000653	CcSEcCtD
Trimethoprim—Leukopenia—Methotrexate—systemic scleroderma	0.000147	0.000651	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000146	0.000647	CcSEcCtD
Trimethoprim—Insomnia—Prednisone—systemic scleroderma	0.000145	0.000642	CcSEcCtD
Trimethoprim—Cough—Methotrexate—systemic scleroderma	0.000143	0.000635	CcSEcCtD
Trimethoprim—Convulsion—Methotrexate—systemic scleroderma	0.000142	0.00063	CcSEcCtD
Trimethoprim—Dyspepsia—Prednisone—systemic scleroderma	0.000141	0.000625	CcSEcCtD
Trimethoprim—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000622	CcSEcCtD
Trimethoprim—Arthralgia—Methotrexate—systemic scleroderma	0.00014	0.000619	CcSEcCtD
Trimethoprim—Myalgia—Methotrexate—systemic scleroderma	0.00014	0.000619	CcSEcCtD
Trimethoprim—Decreased appetite—Prednisone—systemic scleroderma	0.000139	0.000617	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000139	0.000615	CcSEcCtD
Trimethoprim—Constipation—Prednisone—systemic scleroderma	0.000137	0.000607	CcSEcCtD
Trimethoprim—Confusional state—Methotrexate—systemic scleroderma	0.000135	0.000598	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000134	0.000594	CcSEcCtD
Trimethoprim—Feeling abnormal—Prednisone—systemic scleroderma	0.000132	0.000585	CcSEcCtD
Trimethoprim—Nervous system disorder—Methotrexate—systemic scleroderma	0.000131	0.000582	CcSEcCtD
Trimethoprim—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000131	0.000581	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000131	0.000581	CcSEcCtD
Trimethoprim—Skin disorder—Methotrexate—systemic scleroderma	0.00013	0.000576	CcSEcCtD
Trimethoprim—Anorexia—Methotrexate—systemic scleroderma	0.000128	0.000566	CcSEcCtD
Trimethoprim—Urticaria—Prednisone—systemic scleroderma	0.000127	0.000564	CcSEcCtD
Trimethoprim—Abdominal pain—Prednisone—systemic scleroderma	0.000127	0.000561	CcSEcCtD
Trimethoprim—Body temperature increased—Prednisone—systemic scleroderma	0.000127	0.000561	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000122	0.000541	CcSEcCtD
Trimethoprim—Insomnia—Methotrexate—systemic scleroderma	0.000121	0.000537	CcSEcCtD
Trimethoprim—Dyspnoea—Methotrexate—systemic scleroderma	0.00012	0.000529	CcSEcCtD
Trimethoprim—Hypersensitivity—Prednisone—systemic scleroderma	0.000118	0.000523	CcSEcCtD
Trimethoprim—Dyspepsia—Methotrexate—systemic scleroderma	0.000118	0.000522	CcSEcCtD
Trimethoprim—Decreased appetite—Methotrexate—systemic scleroderma	0.000117	0.000516	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000116	0.000512	CcSEcCtD
Trimethoprim—Pruritus—Prednisone—systemic scleroderma	0.000113	0.000502	CcSEcCtD
Trimethoprim—Feeling abnormal—Methotrexate—systemic scleroderma	0.00011	0.000489	CcSEcCtD
Trimethoprim—Diarrhoea—Prednisone—systemic scleroderma	0.00011	0.000486	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00011	0.000485	CcSEcCtD
Trimethoprim—Urticaria—Methotrexate—systemic scleroderma	0.000106	0.000472	CcSEcCtD
Trimethoprim—Dizziness—Prednisone—systemic scleroderma	0.000106	0.00047	CcSEcCtD
Trimethoprim—Abdominal pain—Methotrexate—systemic scleroderma	0.000106	0.000469	CcSEcCtD
Trimethoprim—Body temperature increased—Methotrexate—systemic scleroderma	0.000106	0.000469	CcSEcCtD
Trimethoprim—Vomiting—Prednisone—systemic scleroderma	0.000102	0.000452	CcSEcCtD
Trimethoprim—Rash—Prednisone—systemic scleroderma	0.000101	0.000448	CcSEcCtD
Trimethoprim—Dermatitis—Prednisone—systemic scleroderma	0.000101	0.000447	CcSEcCtD
Trimethoprim—Headache—Prednisone—systemic scleroderma	0.0001	0.000445	CcSEcCtD
Trimethoprim—Hypersensitivity—Methotrexate—systemic scleroderma	9.88e-05	0.000437	CcSEcCtD
Trimethoprim—Nausea—Prednisone—systemic scleroderma	9.53e-05	0.000422	CcSEcCtD
Trimethoprim—Pruritus—Methotrexate—systemic scleroderma	9.48e-05	0.00042	CcSEcCtD
Trimethoprim—Diarrhoea—Methotrexate—systemic scleroderma	9.17e-05	0.000406	CcSEcCtD
Trimethoprim—Dizziness—Methotrexate—systemic scleroderma	8.86e-05	0.000392	CcSEcCtD
Trimethoprim—Vomiting—Methotrexate—systemic scleroderma	8.52e-05	0.000377	CcSEcCtD
Trimethoprim—Rash—Methotrexate—systemic scleroderma	8.45e-05	0.000374	CcSEcCtD
Trimethoprim—Dermatitis—Methotrexate—systemic scleroderma	8.44e-05	0.000374	CcSEcCtD
Trimethoprim—Headache—Methotrexate—systemic scleroderma	8.4e-05	0.000372	CcSEcCtD
Trimethoprim—Nausea—Methotrexate—systemic scleroderma	7.96e-05	0.000353	CcSEcCtD
